1D·

🚨 Medical breakthrough at BioNTech!

Together with Duality Biologics $BNTX (+8,86%) the first major success in oncology:

🔬 In a phase III trial, the precision medicine BNT323 (trastuzumab pamirtecan) showed impressive results in HER2-positive breast cancer.

🎯 The primary study objective was achieved:

The time to disease progression (Progression Free Survival) was significantly extended.

This offers affected patients a new, promising treatment option.

💡 This is a milestone for BioNTech - the company, which became known for its mRNA vaccines against COVID-19, is now also demonstrating its strength in cancer research.

📈 The stock market reacted immediately: the share price rose sharply 🚀

👉 A strong signal that BioNTech could establish itself as a key player in oncology.

#BioNTech
#Krebsforschung
#Onkologie
#Brustkrebs
#MedizinischerDurchbruch
#Innovation

17 Comentários

theGreatShark@theGreatShark

That is beautiful News for many people that suffer❤️ Thanks for sharing

•

Chris@Multibagger

@theGreatShark For me too. $BNTX is my largest position in the portfolio.

•

Brandon90@Brandon90

@theGreatShark true. Thank you🙏🏽

•

Brandon90@Brandon90

@Multibagger only a matter of time before the price explodes 🚀

•

Chris@Multibagger

22H

@Brandon90 I have always said that my target price is 500 by 2030! You can choose whether € or $😉

•

Brandon90@Brandon90

21H

@Multibagger okay and what do you base that on ? Not that I have anything against it🤣 Do you think a new pandemic etc. is more likely because of a cancer cure?

•

Chris@Multibagger

21H

@Brandon90 Today there was only one drug that was reported positively. But they currently have 16 in the pipeline against different types of cancer. I think if 3-4 of them end up positive, the share price is realistic. And I believe that. With Corona, they have proven that they understand MRNA. I have full confidence in the company founders. In my opinion, the investment by Bristol Meyers 2 months ago was not invested in the blue haze. They don't give a few billion if they haven't seen good interim results that the public hasn't seen yet.

•

Brandon90@Brandon90

21H

@Multibagger okay, now I see the 500 € too 😜
Let's hope the others don't come first😩

••

Maximilian@Max095

17H

@Multibagger I prefer to stay invested at $IOVA. No risk no fun 😜🚀

••

Chris@Multibagger

13H

@Max095 every biotech stock is risk.

••

Maximilian@Max095

@Multibagger the big ones like $AMGN rather not

•

Ver mais uma resposta

Soprano@Soprano

21H

"We can't cure your illness, but if you take our medicine, it might not be as bad as usual. So you'll still be ill - but happy"

That sounds familiar somehow.

•

Dan@DanDoDan

Great news, both for those affected and for the shareholders. I had been waiting 3 months for an entry price that made sense for me and got in with a first tranche at €85 last week. How can you actually link a transaction in a post on getquin?

•

Brandon90@Brandon90

@DanDoDan I agree. Anything that helps people to overcome a disease or make it more bearable is an important contribution to humanity. ☺️ and there you see it again. Timing is everything. The profit lies in waiting (buying cheaply) 💰

•

Howard@bardar

23H

And then only 10% on top? Other strange pharmaceutical stocks then increase by 50% or similar...

••

Brandon90@Brandon90

21H

@bardar everything can still come 😜 I think the Germans are generally skeptical about vaccinations and now anyway after Corona. BioNTech has also often been discussed. Maybe that's why the Germans are holding back. The Americans have their own pharmaceutical companies they are betting on. I can't explain it any other way 😬

••